24 May 2013
Keywords: tarceva, nda, filing, completed, usa, genentech, osi
Article | 09 August 2004
The USA's Genentech and OSI Pharmaceuticals have completed thesubmission of a New Drug Application with the US Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 August 2004
23 May 2013
© 2013 thepharmaletter.com